Related Experiment Video

Updated: May 27, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Iron and neurodegeneration in multiple sclerosis

Michael Khalil1, Charlotte Teunissen, Christian Langkammer

  • 1Department of Neurology, Medical University of Graz, A-8036 Graz, Austria.

Multiple Sclerosis International
|November 19, 2011
PubMed

Insights

Iron accumulation in the brain may play a role in multiple sclerosis (MS). Further research using advanced MRI and biomarker analysis is needed to understand iron

Area of Science:

  • Neuroimmunology
  • Neuroimaging
  • Biochemistry

Background:

  • Increased iron deposition is suspected in multiple sclerosis (MS) pathology.
  • Quantitative MRI now allows for precise measurement of brain iron levels.
  • Evidence from CSF, blood, and postmortem studies suggests altered iron homeostasis in MS.

Purpose of the Study:

  • To investigate the potential role of iron accumulation in multiple sclerosis pathogenesis.
  • To explore the controversial hypothesis of chronic cerebrospinal venous insufficiency (CCVI) and its link to brain iron in MS.
  • To determine if iron accumulation is a cause or consequence of MS pathology.

Main Methods:

  • Utilizing advanced magnetic resonance imaging (MRI) techniques for quantitative brain iron assessment.
  • Analyzing iron and iron-related proteins in cerebrospinal fluid (CSF) and serum.
  • Integrating clinical follow-up data with imaging and biomarker analyses.

Main Results:

  • Quantitative MRI enables precise determination of brain iron levels.
  • Studies show abnormal iron and iron-related protein levels in CSF and blood of MS patients.
  • The etiological role of iron accumulation and CCVI in MS remains debated.

Conclusions:

  • The precise implication of iron accumulation in multiple sclerosis pathology requires further elucidation.
  • Combined quantitative MRI and biomarker analysis in longitudinal studies are crucial.
  • Investigating the link between chronic cerebrospinal venous insufficiency and brain iron may offer new insights into MS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...